The application of monoclonal antibodies in cancer diagnosis

References

• Warshawsky D, Landolph JR. Molecular Carcinogenesis and the Molecular Biology of Human Cancer. Taylor & Francis, FL, USA (2005).
   Google Scholar
• Cho WC. Contribution of oncoproteomics to cancer biomarker discovery. Mol. Cancer 6, 25 (2007).
   PubMed Web of Science ®Google Scholar
• Olafsen T, Wu AM. Antibody vectors for imaging. Semin. Nucl. Med. 40(3), 167–181 (2010).
   PubMed Web of Science ®Google Scholar
• Gonzalez SA, Keeffe EB. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy. Clin. Liver Dis. 15(2), 297–306, vii–x (2011).
   PubMedGoogle Scholar
• Negm RS, Verma M, Srivastava S. The promise of biomarkers in cancer screening and detection. Trends Mol. Med. 8(6), 288–293 (2002).
   PubMed Web of Science ®Google Scholar
• Giskeodegard GF, Bertilsson H, Selnaes KM et al. Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness. PLoS ONE 8(4), e62375 (2013).
   PubMed Web of Science ®Google Scholar
• Alokail MS, Al-Daghri N, Abdulkareem A et al. Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk? BMC Cancer 13, 54 (2013).
   PubMed Web of Science ®Google Scholar
• Moestue SA, Dam CG, Gorad SS et al. Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Res. 15(1), R16 (2013).
   PubMed Web of Science ®Google Scholar
• Zhao Y, Lee WN, Xiao GG. Quantitative proteomics and biomarker discovery in human cancer. Expert Rev. Proteomics 6(2), 115–118 (2009).
   PubMed Web of Science ®Google Scholar
• Bartling B, Hofmann HS, Boettger T et al. Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. Lung Cancer 49(2), 145–154 (2005).
   PubMed Web of Science ®Google Scholar
• Opstal-Van Winden AW, Vermeulen RC, Peeters PH, Beijnen JH, Van Gils CH. Early diagnostic protein biomarkers for breast cancer: how far have we come? Breast Cancer Res. Treat. 134(1), 1–12 (2012).
   PubMedGoogle Scholar
• Stein U, Burock S, Herrmann P et al. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS ONE 7(11), e49249 (2012).
   Google Scholar
• Liu M, Li JS, Tian DP, Huang B, Rosqvist S, Su M. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer. Histol. Histopathol. 28(4), 481–492 (2013).
   PubMedGoogle Scholar
• Augustine JJ, Poggio ED, Heeger PS, Hricik DE. Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots. Transplantation 86(4), 529–534 (2008).
   PubMedGoogle Scholar
• Slota M, Lim JB, Dang Y, Disis ML. ELISPOT for measuring human immune responses to vaccines. Expert Rev. Vaccines 10(3), 299–306 (2011).
   PubMed Web of Science ®Google Scholar
• Cooksley-Decasper S, Reiser H, Thommen DS et al. Antibody phage display assisted identification of junction plakoglobin as a potential biomarker for atherosclerosis. PLoS ONE 7(10), e47985 (2012).
   Google Scholar
• Weng X, Liao Q, Li K, Li Y, Mi M, Zhong D. Screening serum biomarker of knee osteoarthritis using a phage display technique. Clin. Biochem. 45(4–5), 303–308 (2012).
   Google Scholar
• Wang M, Li X, Chen J et al. Screening and evaluating the mimic peptides as a useful serum biomarker of ankylosing spondylitis using a phage display technique. Rheumatol. Int. 31(8), 1009–1016 (2011).
   PubMedGoogle Scholar
• Park JP, Cropek DM, Banta S. High affinity peptides for the recognition of the heart disease biomarker troponin I identified using phage display. Biotechnol. Bioeng. 105(4), 678–686 (2010).
   PubMed Web of Science ®Google Scholar
• Tolmachev V, Nilsson FY, Widstrom C et al. 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors. J. Nucl. Med. 47(5), 846–853 (2006).
   PubMedGoogle Scholar
• Schwitalle Y, Kloor M, Eiermann S et al. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134(4), 988–997 (2008).
   PubMed Web of Science ®Google Scholar
• Tan HT, Low J, Lim SG, Chung MC. Serum autoantibodies as biomarkers for early cancer detection. FEBS J. 276(23), 6880–6904 (2009).
   PubMed Web of Science ®Google Scholar
• Tabernero MD, Lv LL, Anderson KS. Autoantibody profiles as biomarkers of breast cancer. Cancer Biomark. 6(5–6), 247–256 (2010).
   PubMedGoogle Scholar
• Shukla GS, Krag DN, Peletskaya EN et al. Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies. Cancer Immunol. Immunother. 62(8), 1397–1410 (2013).
   PubMed Web of Science ®Google Scholar
• Hamdan MH, Desiderio DM, Nibbering NM. Cancer Biomarkers: Analytical Techniques for Discovery. Wiley, NJ, USA (2007).
   Google Scholar
• Xiao GG, Garg M, Lim S, Wong D, Go VL, Lee WN. Determination of protein synthesis in vivo using labeling from deuterated water and analysis of MALDI-TOF spectrum. J. Appl. Physiol. 104(3), 828–836 (2008).
   PubMed Web of Science ®Google Scholar
• Zhao Y, Lee WN, Lim S et al. Quantitative proteomics: measuring protein synthesis using 15N amino acid labeling in pancreatic cancer cells. Anal. Chem. 81(2), 764–771 (2009).
   PubMedGoogle Scholar
• Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1(5), 252–262 (2005).
   PubMed Web of Science ®Google Scholar
• Schuhmacher J, Kaul S, Klivenyi G et al. Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies. Cancer Res. 61(9), 3712–3717 (2001).
   PubMedGoogle Scholar
• Kopf E, Zharhary D. Antibody arrays--an emerging tool in cancer proteomics. Int. J. Biochem. Cell Biol. 39(7–8), 1305–1317 (2007).
   PubMedGoogle Scholar
• Gronborg M, Kristiansen TZ, Iwahori A et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. cell. Proteomics 5(1), 157–171 (2006).
   PubMed Web of Science ®Google Scholar
• Sanchez-Carbayo M. Antibody array-based technologies for cancer protein profiling and functional proteomic analyses using serum and tissue specimens. Tumour Biol. 31(2), 103–112 (2010).
   PubMedGoogle Scholar
• Mann M. Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell Biol. 7(12), 952–958 (2006).
   PubMed Web of Science ®Google Scholar
• Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. cell. Proteomics 1(5), 376–386 (2002).
   PubMed Web of Science ®Google Scholar
• Zola H, Roberts Thomson P. Monoclonal antibodies: diagnostic uses. In: eLS. John Wiley & Sons, Ltd, NJ, USA (2001).
   Google Scholar
• Miller JC, Zhou H, Kwekel J et al. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics 3(1), 56–63 (2003).
   PubMed Web of Science ®Google Scholar
• Varnum SM, Woodbury RL, Zangar RC. A protein microarray ELISA for screening biological fluids. Methods Mol. Biol. 264, 161–172 (2004).
   PubMedGoogle Scholar
• Hudelist G, Pacher-Zavisin M, Singer CF et al. Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue. Breast Cancer Res. Treat. 86(3), 281–291 (2004).
   PubMed Web of Science ®Google Scholar
• Zajac A, Song D, Qian W, Zhukov T. Protein microarrays and quantum dot probes for early cancer detection. Colloids Surf. B Biointerfaces 58(2), 309–314 (2007).
   PubMed Web of Science ®Google Scholar
• Nettikadan S, Radke K, Johnson J et al. Detection and quantification of protein biomarkers from fewer than 10 cells. Molecular Cell. Proteomics 5(5), 895–901 (2006).
   PubMedGoogle Scholar
• Li Y, Lee HJ, Corn RM. Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging. Anal. Chem. 79(3), 1082–1088 (2007).
   PubMedGoogle Scholar
• Saviranta P, Okon R, Brinker A, Warashina M, Eppinger J, Geierstanger BH. Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime. Clin. Chem. 50(10), 1907–1920 (2004).
   PubMedGoogle Scholar
• Shafer MW, Mangold L, Partin AW, Haab BB. Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease. Prostate 67(3), 255–267 (2007).
   PubMedGoogle Scholar
• Huang R, Lin Y, Shi Q et al. Enhanced protein profiling arrays with ELISA-based amplification for high-throughput molecular changes of tumor patients' plasma. Clin. Cancer Res. 10(2), 598–609 (2004).
   PubMedGoogle Scholar
• Sethi S, Ali S, Philip PA, Sarkar FH. Clinical advances in molecular biomarkers for cancer diagnosis and therapy. Int. J. Mol. Sci. 14(7), 14771–14784 (2013).
   PubMed Web of Science ®Google Scholar
• Yewale C, Baradia D, Vhora I, Misra A. Proteins: emerging carrier for delivery of cancer therapeutics. Expert Opin. Drug Deliv. 10(10), 1429–1448 (2013).
   PubMed Web of Science ®Google Scholar
• Rudnick SI, Adams GP. Affinity and avidity in antibody-based tumor targeting. Cancer Biother. Radiopharm. 24(2), 155–161 (2009).
   PubMed Web of Science ®Google Scholar
• O'Shannessy DJ, Somers EB, Smale R, Fu YS. Expression of folate receptor-alpha (FRA) in gynecologic malignancies and its relationship to the tumor type. Int. J. Gynecol. Pathol. 32(3), 258–268 (2013).
   PubMed Web of Science ®Google Scholar
• Kudo-Saito C, Shirako H, Ohike M, Tsukamoto N, Kawakami Y. CCL2 is critical for immunosuppression to promote cancer metastasis. Clinical Exp. Metastasis 30(4), 393–405 (2013).
   PubMed Web of Science ®Google Scholar
• Cappuzzo F, Cho YG, Sacconi A et al. p95HER2 truncated form in resected non-small cell lung cancer. J. Thorac. Oncol. 7(3), 520–527 (2012).
   PubMed Web of Science ®Google Scholar
• Sanchez-Carbayo M. Antibody arrays: technical considerations and clinical applications in cancer. Clin. Chem. 52(9), 1651–1659 (2006).
   PubMedGoogle Scholar
• Takeuchi H, Ueda M, Oyama T, Shimizu Y, Kitagawa Y. Molecular diagnosis and translymphatic chemotherapy targeting sentinel lymph nodes of patients with early gastrointestinal cancers. Digestion 82(3), 187–191 (2010).
   PubMedGoogle Scholar
• Borrebaeck CA, Wingren C. High-throughput proteomics using antibody microarrays: an update. Expert Rev. Mol. Diagn. 7(5), 673–686 (2007).
   PubMed Web of Science ®Google Scholar
• Dotan N, Altstock RT, Schwarz M, Dukler A. Anti-glycan antibodies as biomarkers for diagnosis and prognosis. Lupus 15(7), 442–450 (2006).
   PubMed Web of Science ®Google Scholar
• Chen S, Laroche T, Hamelinck D et al. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat. Methods 4(5), 437–444 (2007).
   PubMedGoogle Scholar
• Lim SM, Hwang JW, Bae SK et al. Quantitative analysis of ERK signaling inhibition in colon cancer cell lines using phospho-specific flow cytometry. Anal. Quant. Cytol. Histol. 34(6), 309–316 (2012).
   Google Scholar
• Wang Y, Fang F, Shi C et al. Evaluation of a method for the simultaneous detection of multiple tumor markers using a multiplex suspension bead array. Clin. Biochem. 45(16–17), 1394–1398 (2012).
   PubMedGoogle Scholar
• Theilacker N, Roller EE, Barbee KD, Franzreb M, Huang X. Multiplexed protein analysis using encoded antibody-conjugated microbeads. J. Royal Soc. Interface 8(61), 1104–1113 (2011).
   PubMedGoogle Scholar
• Liu N, Liang W, Ma X et al. Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology. Biosens. Bioelectron. 47, 92–98 (2013).
   PubMed Web of Science ®Google Scholar
• Xie C, Wang G. Development of simultaneous detection of total prostate-specific antigen (tPSA) and free PSA with rapid bead-based immunoassay. J. Clin. Lab. Anal. 25(1), 37–42 (2011).
   PubMedGoogle Scholar
• Sepiashvili L, Hui A, Ignatchenko V et al. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy. Mol. Cell. Proteomics 11(11), 1404–1415 (2012).
   PubMed Web of Science ®Google Scholar
• Kim BK, Lee JW, Park PJ et al. The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res. 11(2), R22 (2009).
   Google Scholar
• Yamada Y, Arao T, Matsumoto K et al. Plasma concentrations of VCAM-1 and PAI-1: a predictive biomarker for post-operative recurrence in colorectal cancer. Cancer Sci. 101(8), 1886–1890 (2010).
   PubMedGoogle Scholar
• Lin X, Xie J, Chen X. Protein-based tumor molecular imaging probes. Amino acids 41(5), 1013–1036 (2011).
   PubMed Web of Science ®Google Scholar
• Friedrich L, Stangl S, Hahne H et al. Bacterial production and functional characterization of the Fab fragment of the murine IgG1/lambda monoclonal antibody cmHsp70.1, a reagent for tumour diagnostics. Protein Eng. Des. Sel. 23(4), 161–168 (2010).
   PubMedGoogle Scholar
• Casey JL, Napier MP, King DJ et al. Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study. Br. J. Cancer 86(9), 1401–1410 (2002).
   PubMedGoogle Scholar
• Song S, Li B, Wang L et al. A cancer protein microarray platform using antibody fragments and its clinical applications. Mol. Biosyst. 3(2), 151–158 (2007).
   PubMedGoogle Scholar
• Kondo N, Temma T, Shimizu Y et al. Miniaturized antibodies for imaging membrane type-1 matrix metalloproteinase in cancers. Cancer Sci. 104(4), 495–501 (2013).
   PubMedGoogle Scholar
• Tang Y, Wang J, Scollard DA et al. Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using (111)In-trastuzumab (Herceptin) Fab fragments. Nucl. Med. Biol. 32(1), 51–58 (2005).
   PubMedGoogle Scholar
• Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 23(9), 1126–1136 (2005).
   PubMed Web of Science ®Google Scholar
• Wang WW, Ang SF, Kumar R et al. Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma. PLoS ONE 8(7), e68904 (2013).
   Google Scholar
• Schwenk JM, Gry M, Rimini R, Uhlen M, Nilsson P. Antibody suspension bead arrays within serum proteomics. J. Proteome Res. 7(8), 3168–3179 (2008).
   PubMed Web of Science ®Google Scholar
• Bohunicky, B, Mousa. SA. Biosensors:the new wave in canceer diagnosis. Nanotechnol. Sci. Appl. 4, 1–10 (2010).
   PubMedGoogle Scholar
• Mathur A, Blais S, Goparaju CM, Neubert T, Pass H, Levon K. Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting. PLoS ONE 8(3), e57681 (2013).
   Google Scholar
• Kim KW, Song J, Kee JS, Liu Q, Lo GQ, Park MK. Label-free biosensor based on an electrical tracing-assisted silicon microring resonator with a low-cost broadband source. Biosens. Bioelectron. 46, 15–21 (2013).
   PubMed Web of Science ®Google Scholar
• Li J, Dowdy S, Tipton T et al. HE4 as a biomarker for ovarian and endometrial cancer management. Expert Rev. Mol. Diagn. 9(6), 555–566 (2009).
   PubMed Web of Science ®Google Scholar
• Yurkovetsky Z, Skates S, Lomakin A et al. Development of a multimarker assay for early detection of ovarian cancer. J. Clin. Oncol. 28(13), 2159–2166 (2010).
   PubMed Web of Science ®Google Scholar
• Magro CM, Yang SE, Zippin JH, Zembowicz A. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins. Arch. Pathol. Lab. Med. 136(12), 1558–1564 (2012).
   PubMed Web of Science ®Google Scholar
• Babel I, Barderas R, Diaz-Uriarte R, Martinez-Torrecuadrada JL, Sanchez-Carbayo M, Casal JI. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol. Cell. Proteomics 8(10), 2382–2395 (2009).
   PubMed Web of Science ®Google Scholar
• Na K, Jeong SK, Lee MJ et al. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients. Int. J. Cancer 133(2), 408–415 (2013).
   PubMedGoogle Scholar
• Yaskiv O, Rubin BP, He H, Falzarano S, Magi-Galluzzi C, Zhou M. ERG protein expression in human tumors detected with a rabbit monoclonal antibody. Am. J. Clin. Pathol. 138(6), 803–810 (2012).
   PubMedGoogle Scholar
• Silsirivanit A, Araki N, Wongkham C et al. CA-S27: a novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma. Cancer Sci. 104(10), 1278–1284 (2013).
   PubMed Web of Science ®Google Scholar
• Pedchenko T, Mernaugh R, Parekh D, Li M, Massion PP. Early detection of NSCLC with scFv selected against IgM autoantibody. PLoS ONE 8(4), e60934 (2013).
   Google Scholar
• Ramakrishnan B, Boeggeman E, Manzoni M et al. Multiple site-specific in vitro labeling of single-chain antibody. Bioconjug. Chem. 20(7), 1383–1389 (2009).
   PubMedGoogle Scholar